T
Torahiko Jinta
Researcher at International University, Cambodia
Publications - 60
Citations - 192
Torahiko Jinta is an academic researcher from International University, Cambodia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 44 publications receiving 120 citations.
Papers
More filters
Journal ArticleDOI
High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series
TL;DR: Seven mechanically ventilated patients with acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID‐19) who received early treatment with high‐dose, short‐term systemic corticosteroids to prevent cytokine overproduction are reported.
Journal ArticleDOI
A Case of Pulmonary Tumor Thrombotic Microangiopathy Diagnosed by Transbronchial Lung Biopsy and Treated with Chemotherapy and Long-Term Oxygen and Anticoagulation Therapies
Atsushi Kitamura,Naoki Nishimura,Torahiko Jinta,Rika Suda,Yasuhiko Yamano,Genta Ishikawa,Yutaka Tomishima,Tsuyoshi Hamaoka,Koyu Suzuki,Naohiko Chohnabayashi +9 more
TL;DR: A 41-year-old woman, who underwent breast resection for cancer of the right breast and adjuvant chemotherapy 2 years ago, was admitted to hospital due to shortness of breath upon exertion and a transbronchial lung biopsy revealed breast cancer metastasis and pulmonary tumor thrombotic microangiopathy (PTTM).
Journal ArticleDOI
Health care worker burnout after the first wave of the coronavirus disease 2019 (COVID-19) pandemic in Japan.
Takahiro Matsuo,Fumika Taki,Daiki Kobayashi,Torahiko Jinta,Chiharu Suzuki,Akiko Ayabe,Fumie Sakamoto,Kazuyo Kitaoka,Yuki Uehara,Nobuyoshi Mori,Tsuguya Fukui +10 more
TL;DR: In this article, the authors conducted an online cross-sectional survey of health care workers (HCWs) from June 15 to July 6, 2020, at a tertiary hospital in Tokyo, Japan, to determine the prevalence of burnout according to job category and explore its association with certain factors.
Journal ArticleDOI
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial
Kazuma Nagata,Takeo Horie,Naohiko Chohnabayashi,Torahiko Jinta,Ryosuke Tsugitomi,Akira Shiraki,Fumiaki Tokioka,T. Kadowaki,Akira Watanabe,Motonari Fukui,Takamasa Kitajima,Susumu Sato,Toru Tsuda,Nobuhito Kishimoto,Hideo Kita,Yoshihiro Mori,Masayuki Nakayama,Kenichi Takahashi,Tomomasa Tsuboi,Makoto Yoshida,Osamu Hataji,Satoshi Fuke,Michiko Kagajo,Hiroki Nishine,Hiroyasu Kobayashi,Hiroyuki Nakamura,Miyuki Okuda,Sayaka Tachibana,Shohei Takata,Hisayuki Osoreda,Kenichi Minami,Takashi Nishimura,Takashi Ishida,Jiro Terada,Naoko Takeuchi,Yasuo Kohashi,Hiromasa Inoue,Yoko Nakagawa,Takashi Kikuchi,Keisuke Tomii +39 more
TL;DR: High-flow nasal cannula significantly improved health-related quality of life scores, peripheral oxygen saturation, pulmonary function, and specific pulmonary function parameters and is a reasonable therapeutic option for patients with stable hypercapnic chronic obstructive pulmonary disease and a history of exacerbations.
Journal ArticleDOI
Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy
Shosei Ro,Naoki Nishimura,Ryosuke Imai,Yutaka Tomishima,Clara So,Manabu Murakami,Kohei Okafuji,Atsushi Kitamura,Torahiko Jinta,Tomohide Tamura +9 more
TL;DR: In this article, the role of high-dose methylprednisolone pulse therapy in reducing mortality in critically ill patients with coronavirus disease 2019 (COVID-19) has also been documented.